Search results
Results From The WOW.Com Content Network
Nature was one of the world's most cited scientific journals by the Science Edition of the 2022 Journal Citation Reports (with an ascribed impact factor of 50.5), [1] making it one of the world's most-read and most prestigious academic journals. [2] [3] [4] As of 2012, it claimed an online readership of about three million unique readers per month.
The impact factor relates to a specific time period; it is possible to calculate it for any desired period. For example, the JCR also includes a five-year impact factor, which is calculated by dividing the number of citations to the journal in a given year by the number of articles published in that journal in the previous five years. [14] [15]
The values for Nature journals lie well above the expected ca. 1:1 linear dependence because those journals contain a significant fraction of editorials. CiteScore was designed to compete with the two-year JCR impact factor, which is currently the most widely used journal metric. [7] [8] Their main differences are as follows: [9]
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
For instance, most papers in Nature (impact factor 38.1, 2016) were only cited 10 or 20 times during the reference year (see figure). Journals with a lower impact (e.g. PLOS ONE, impact factor 3.1) publish many papers that are cited 0 to 5 times but few highly cited articles. [21]
Nature Communications is a peer-reviewed, open access, scientific journal published by Nature Portfolio since 2010. It is a multidisciplinary journal that covers the natural sciences, including physics, chemistry, earth sciences, medicine, and biology. The journal has editorial offices in London, Berlin, New York City, and Shanghai.
Nature Biotechnology is a monthly peer-reviewed scientific journal published by Nature Portfolio. The editor-in-chief is Barbara Cheifet who heads an in-house team of editors. [ 1 ] The focus of the journal is biotechnology including research results and the commercial business sector of this field.
Nature Reviews Disease Primers is a peer-reviewed medical journal published by Nature Portfolio.It was established in 2015. [1] The editor-in-chief is Clemens Thoma. [2] The journal publishes broad review articles about disease areas, offering a global overview of the field and outlining "key open research questions". [3]